COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options

COVID-19: иммунопатология, патофизиологические механизмы и варианты лечения
Arno R. Bourgonje, Amaal Eman Abdulle, Jan‐Luuk Hillebrands, Peter H. J. van der Voort, Douwe J. Mulder, Harry van Goor, Marcel G. M. Olde Rikkert, Johannes G. van der Hoeven, Wilfred F.A. den Dunnen, Eelke M. Bos, Larissa E. van Eijk, Mathijs Binkhorst, Annette K. Offringa, Nikola Kolundžić
2021-02-16

COVID-19 immunopathologyCOVID-19 vaccinesSARS-CoV-2 infectionacute respiratory distress syndromemulti-organ failure
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally despite the worldwide implementation of preventive measures to combat the disease. Although most COVID-19 cases are characterised by a mild, self-limiting disease course, a considerable subset of patients develop a more severe condition, varying from pneumonia and acute respiratory distress syndrome (ARDS) to multi-organ failure (MOF). Progression of COVID-19 is thought to occur as a result of a complex interplay between multiple pathophysiological mechanisms, all of which may orchestrate SARS-CoV-2 infection and contribute to organ-specific tissue damage. In this respect, dissecting currently available knowledge of COVID-19 immunopathogenesis is crucially important, not only to improve our understanding of its pathophysiology but also to fuel the rationale of both novel and repurposed treatment modalities. Various immune-mediated pathways during SARS-CoV-2 infection are relevant in this context, which relate to innate immunity, adaptive immunity, and autoimmunity. Pathological findings in tissue specimens of patients with COVID-19 provide valuable information with regard to our understanding of pathophysiology as well as the development of evidence-based treatment regimens. This review provides an updated overview of the main pathological changes observed in COVID-19 within the most commonly affected organ systems, with special emphasis on immunopathology. Current management strategies for COVID-19 include supportive care and the use of repurposed or symptomatic drugs, such as dexamethasone, remdesivir, and anticoagulants. Ultimately, prevention is key to combat COVID-19, and this requires appropriate measures to attenuate its spread and, above all, the development and implementation of effective vaccines. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
1
COVID-19 severity ranges from mild, self-limiting illness to pneumonia, acute respiratory distress syndrome, and multi-organ failure.
2
Current management combines supportive care with repurposed or symptomatic therapies, including dexamethasone, remdesivir, and anticoagulants.
3
Disease progression reflects interactions among innate immunity, adaptive immunity, autoimmunity, and other pathophysiological mechanisms that drive organ-specific tissue damage.
4
Effective prevention depends primarily on measures that reduce transmission and the development and implementation of effective vaccines.
5
Pathological examination of patient tissues provides insights into COVID-19 pathophysiology and supports development of evidence-based treatment strategies.

COVID-19 (SARS-CoV-2 infection)

Immunopathology, pathophysiological mechanisms, organ-specific tissue damage, and treatment options

Publication Details
Publication Date
2021-02-16
Journal
Publisher
ISSN
Cited by
152
Access Type
Author Information
Authors
Arno R. Bourgonje
Amaal Eman Abdulle
Jan‐Luuk Hillebrands
Peter H. J. van der Voort
Douwe J. Mulder
Harry van Goor
Marcel G. M. Olde Rikkert
Johannes G. van der Hoeven
Wilfred F.A. den Dunnen
Eelke M. Bos
Larissa E. van Eijk
Mathijs Binkhorst
Annette K. Offringa
Nikola Kolundžić
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%